Error: Could not add to watchlist. X
+ Watchlist

Hemispherx Biopharma Inc

HEB:US
NYSE MKT LLC
0.720
USD
0.143
24.76%
As of 3:59 PM EDT 4/24/2017
Open
0.600
Day Range
0.580 - 0.750
Volume
1,310,217
Previous Close
0.577
52Wk Range
0.392 - 2.636
1 Yr Return
-54.32%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
0.600
Day Range
0.580 - 0.750
Volume
1,310,217
Previous Close
0.577
52Wk Range
0.392 - 2.636
1 Yr Return
-54.32%
YTD Return
4.38%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.462
Market Cap (m USD)
16.527
Shares Outstanding (m)
26.187
Price/Sales (TTM)
172.58
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.95%
% Price Change
+0.93%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Hemispherx Biopharma, Inc. is a biopharmaceutical company that focuses on the development of nucleic acids to enhance the natural anti-viral defense systems of the human body. The Company's lead product, Ampligen, is undergoing clinical trials for the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Address
1617 JFK Boulevard
Suite 660
Philadelphia, PA 19103
United States
Phone
1-215-988-0080
Show More